Therapeutic Approaches to Fatigue in Multiple Sclerosis: Anna Kratz, PhD
Discussing cognitive behavioral therapy for patients with MS, the associate professor of Physical Medicine and Rehabilitation and research nonclinical psychologist at the University of Michigan Medicine mentioned different therapeutic options that can benefit this patient population. [WATCH TIME: 3 minutes]
WATCH TIME: 3 minutes
“Taking a multidisciplinary approach allows you to tweak across a bunch of different domains, potentially. If somebody is just on a medication, for instance, your options for tweaking their care over time are really limited. It's really about making care more patient-centered, [and] more tailored to every person at a given time.”
A multidisciplinary approach to multiple sclerosis (MS) treatment can generate benefits, and when addressing fatigue, both cognitive behavioral therapy and acceptance and commitment therapy can be particularly effective in the short- and long-term treatment plan. Anna Kratz, PhD, associate professor of Physical Medicine & Rehabilitation and a research nonclinical psychologist, University of Michigan Medicine, spoke with NeurologyLive® on the integration of these therapies, which she noted many MS clinicians may be surprised to learn are available for their patients as a tool for symptom management.
Kratz further stressed the need to consider a variety of options for patients and identifying “what works for whom,” while also considering how treatment plans might change or need to be modified over the disease course. Precision health and tailored interventions for fatigue were the main focus of her presentation at the
For more coverage of CMSC 2021,
REFERENCE
Kratz A. Combined approaches to fatigue in MS. Presented at: CMSC 2021; October 25-28, 2021; Orlando, FL. REHAB1.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
- Current Challenges and New Opportunities Ahead for Women in Neurology
September 15th 2025
- Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
September 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025